Countries race to strengthen compulsory licensing legislation →

With potential vaccines racing through the development pipeline at dizzying speeds and existing drugs showing promise as possible treatments for COVID-19, pressure is mounting to ensure all countries have affordable access to any therapeutics or vaccines that eventually emerge.

That is far from guaranteed, but governments of lower- and middle-income countries also have tools they can use to secure affordable access for their citizens, particularly under international trade agreements that allow them to override pharmaceutical patents. Read more.

---